Infliximab was launched by Janssen over 20 years ago under the name Remicade. It continues to be a biologic therapy…
We are all aware of the importance of completing both doses of Covid-19 vaccines to get the best protection. In…
It is very exciting to share the news that many of you with high-risk health conditions, will be eligible to…
Charlton Health is always on the lookout for great educational resources to share with our patients. We love sharing the…
This week we are happy to share a great learning opportunity. COVID Discussions is a weekly meeting where a group…
Recently I was asked if a person’s TNF level could be measured to know if a biologic that lowers TNF…
In writing this blog, we are all aware that the vaccine distribution continues to be updated. Phase 2 of vaccine…
Charlton Health is proud to announce that the first dose in Canada of the biosimilar adalimumab, known as Amgevita (produced…
The American College of Rheumatology (ACR) is a prominent organization that provides expert guidance on the diagnosis and treatment of…
Since our last blog providing guidance for the COVID-19 vaccine, we have had many calls asking if patients on disease…